Opus Genetics Inc CEO George Magrath Purchases 100,000 Shares

Author's Avatar
Nov 20, 2024
Article's Main Image

On November 18, 2024, George Magrath, the Chief Executive Officer of Opus Genetics Inc, acquired 100,000 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now holds a total of 492,950 shares in the company. Opus Genetics Inc (IRD, Financial) is a biotechnology company focused on developing gene therapies for inherited retinal diseases. The company aims to address unmet medical needs in the field of ophthalmology. The insider's recent purchase is part of a broader trend of insider buying at Opus Genetics Inc. Over the past year, there have been six insider buys and no insider sells, indicating a positive sentiment among the company's insiders. 1859024369033048064.png On the day of the purchase, shares of Opus Genetics Inc were trading at $1.01, giving the company a market cap of $27.884 million. The stock's GF Value was estimated at $0.77, resulting in a price-to-GF-Value ratio of 1.31. This suggests that the stock is modestly overvalued based on its GF Value. 1859024455414738944.png The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, along with future estimates of business performance from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.